These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 139317)

  • 1. Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate.
    Horton RW; Anlezark GM; Sawaya MC; Meldrum BS
    Eur J Pharmacol; 1977 Feb; 41(4):387-97. PubMed ID: 139317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.
    Anlezark G; Horton RW; Meldrium BS; Sawaya CB
    Biochem Pharmacol; 1976 Feb; 25(4):413-7. PubMed ID: 779794
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: gamma-Aminobutyric acid metabolism and the anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate.
    Anlezark GM; Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Br J Pharmacol; 1976 Mar; 56(3):383P-384P. PubMed ID: 769882
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticonvulsant activity of di-n-propylacetate and brain monoamine metabolism in the rat.
    Abed WT
    Clin Exp Pharmacol Physiol; 1990 Jan; 17(1):11-6. PubMed ID: 1693553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of di-n-propylacetate on the 'binding of GABA to synaptosome-enriched fraction of rat cerebral cortex.
    Kulig BM; Gonzalez-Portal C; Somoza E; Defeudis FV
    Psychopharmacology (Berl); 1977 Aug; 53(3):255-7. PubMed ID: 408853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the mechanism of action of valproid acid].
    Löscher W; Frey HH
    Arzneimittelforschung; 1977; 27(5):1081-2. PubMed ID: 328017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of sodium valproate on gamma-aminobutyrate metabolism and behaviour in naive and ethanolamine-O-sulphate pretreated rats and mice.
    Phillips NI; Fowler LJ
    Biochem Pharmacol; 1982 Jul; 31(13):2257-61. PubMed ID: 6812585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-aminobutyric acid (GABA) and sleep. The influence of di-n-propylacetic acid on sleep in man.
    Schneider E; Ziegler B; Maxion H
    Eur Neurol; 1977; 15(3):146-52. PubMed ID: 192556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Picrotoxin convulsions and GABA metabolism after injection of anticonvulsants in chicks.
    Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Eur J Pharmacol; 1976 Nov; 40(1):101-6. PubMed ID: 991920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Di-n-propylacetic acid--profile of anticonvulsant activity in mice.
    Frey HH; Löscher W
    Arzneimittelforschung; 1976 Feb; 26(2):299-301. PubMed ID: 779804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the pharmacology of inhibitors of GABA-metabolism.
    Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):119-28. PubMed ID: 6782493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant and antiaggressive properties of di-n-propyl acetate after repeated treatment.
    Simler S; Ciesielski L; Klein M; Mandel P
    Neuropharmacology; 1982 Feb; 21(2):133-40. PubMed ID: 6801539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anticonvulsants and gamma-aminobutyric acid (GABA)-mimetic drugs on immunoreactive somatostatin and GABA contents in the rat brain.
    Nagaki S; Kato N; Minatogawa Y; Higuchi T
    Life Sci; 1990; 46(22):1587-95. PubMed ID: 1972258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modification of the ethanol withdrawal syndrome in rats by di-n-propylacetate.
    Noble EP; Gillies R; Vigran R; Mandel P
    Psychopharmacologia; 1976 Mar; 46(2):127-31. PubMed ID: 781711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of di-n-propylacetate, gabaculine, and aminooxyacetic acid: anticonvulsant activity and the gamma-aminobutyrate system.
    Wood JD; Kurylo E; Tsui SK
    J Neurochem; 1981 Dec; 37(6):1440-7. PubMed ID: 6801201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic treatment with amino-oxyacetic acid or sodium n-dipropylacetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats.
    Emson PC
    J Neurochem; 1976 Dec; 27(6):1489-94. PubMed ID: 794443
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice.
    Löscher W
    Biochem Pharmacol; 1982 Mar; 31(5):837-42. PubMed ID: 6805473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sodium dipropylacetate on gamma-aminobutyric acid and biogenic amines in rat brain.
    Kukino K; Deguchi T
    Chem Pharm Bull (Tokyo); 1977 Sep; 25(9):2257-62. PubMed ID: 338171
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of anticonvulsant drugs on the cerebral enzymes metabolizing GABA.
    Sawaya MC; Horton RW; Meldrum BS
    Epilepsia; 1975 Nov; 16(4):649-55. PubMed ID: 9890792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amino-oxyacetic acid, ethanolamine-O-sulphate and GABA on the contents of GABA and various amines in brain slices.
    Starr MS; Tanner T
    J Neurochem; 1975 Nov; 25(5):573-7. PubMed ID: 1194914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.